List of Mergers and Acquisitions

  • MIRA PHARMACEUTICALS, INC.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000164117225003889

      Corporate Action: Acquisition

      Summary preview: MIRA Pharmaceuticals, Inc. received a notification from the Nasdaq Listing Qualifications Staff on A...

    • Filing Date: March 24, 2025

      Accession Number: 000164117225000199

      Corporate Action: Acquisition

      Summary preview: On March 19, 2025, MIRA Pharmaceuticals, Inc. entered into a binding letter of intent with SKNY Phar...

  • Mycotopia Therapies, Inc.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000109690625000487

      Corporate Action: Acquisition

      Summary preview: AIBotics, Inc. focuses on the advancement of treatments for mental health problems through the study...

  • NSTS Bancorp, Inc.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000143774925011792

      Corporate Action: Merger

      Summary preview: NSTS Bancorp, Inc. has filed a definitive proxy statement for its 2025 Annual Meeting of Stockholder...

  • RENASANT CORP

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000071507225000128

      Corporate Action: Merger

      Summary preview: Renasant Corporation announces a post-effective amendment to its Form S-4 registration statement, or...

    • Filing Date: April 4, 2025

      Accession Number: 000071507225000123

      Corporate Action: Merger

      Summary preview: On April 1, 2025, Renasant Corporation completed a merger with The First Bancshares, Inc. as outline...

    • Filing Date: March 17, 2025

      Accession Number: 000071507225000093

      Corporate Action: Merger

      Summary preview: On March 17, 2025, Renasant Corporation announced via a press release that it has received all neces...

    • Filing Date: March 12, 2025

      Accession Number: 000071507225000085

      Corporate Action: Merger

      Summary preview: The document serves as a proxy statement for Renasant Corporation, detailing the agenda for the 2025...

    • Filing Date: February 26, 2025

      Accession Number: 000071507225000057

      Corporate Action: Merger

      Summary preview: Renasant Corporation announces its 2025 Annual Meeting of Shareholders scheduled for April 22, 2025,...

  • Roth CH Acquisition Co.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000182912625002556

      Corporate Action: Merger

      Summary preview: Roth CH Acquisition Co. has provided an important update regarding its merger with Sharon AI Inc. Th...

    • Filing Date: March 28, 2025

      Accession Number: 000182912625002116

      Corporate Action: Merger

      Summary preview: Roth CH Acquisition Co. filed its Annual Report on Form 10-K for the fiscal year ended December 31, ...

    • Filing Date: March 12, 2025

      Accession Number: 000182912625001731

      Corporate Action: Merger

      Summary preview: Roth CH Acquisition Co. announces a Business Combination Agreement with Sharon AI, Inc., focusing on...

    • Filing Date: February 28, 2025

      Accession Number: 000182912625001269

      Corporate Action: Acquisition

      Summary preview: On February 27, 2025, Sharon AI and New Era Helium announced their intention to acquire a 200-acre s...

    • Filing Date: January 30, 2025

      Accession Number: 000182912625000573

      Corporate Action: Merger

      Summary preview: Roth CH Acquisition Co. has executed a Business Combination Agreement (BCA) with Sharon AI Inc. The ...

  • Royalty Pharma plc

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000114036125013380

      Corporate Action: Acquisition

      Summary preview: On April 11, 2025, Royalty Pharma plc disclosed an amendment to a previously entered Membership Inte...

    • Filing Date: April 11, 2025

      Accession Number: 000114036125013382

      Corporate Action: Acquisition

      Summary preview: On April 11, 2025, Royalty Pharma plc announced an amendment to the Membership Interests Purchase Ag...

    • Filing Date: April 11, 2025

      Accession Number: 000114036125013376

      Corporate Action: Acquisition

      Summary preview: Royalty Pharma plc announces a significant agreement to acquire its external manager, RP Management,...

    • Filing Date: March 5, 2025

      Accession Number: 000095010325003064

      Corporate Action: Acquisition

      Summary preview: Royalty Pharma plc is set to acquire its external manager through a Membership Interest Purchase Agr...

    • Filing Date: February 13, 2025

      Accession Number: 000114036125004116

      Corporate Action: Acquisition

      Summary preview: Royalty Pharma plc has announced that it is acquiring its external manager, RP Management, LLC (RPM)...

  • Scienture Holdings, Inc.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000164117225003812

      Corporate Action: Acquisition

      Summary preview: On April 8, 2025, Scienture Holdings, Inc. entered into two agreements with Tollo Health, Inc. for s...

    • Filing Date: January 13, 2025

      Accession Number: 000149315225001998

      Corporate Action: Acquisition

      Summary preview: Scienture Holdings, Inc. submitted a response to the U.S. Securities and Exchange Commission regardi...

    • Filing Date: December 30, 2024

      Accession Number: 000149315224052473

      Corporate Action: Acquisition

      Summary preview: On December 30, 2024, Scienture Holdings, Inc. filed an Information Statement with the SEC to notify...

  • Soleus Capital Master Fund, L.P.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000121390025031218

      Corporate Action: Acquisition

      Summary preview: This Amendment to Schedule 13D, filed by Soleus Capital Master Fund, L.P., updates the beneficial ow...

  • Sunshine Lake Pharma Co., Ltd.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000110465925033911

      Corporate Action: Merger

      Summary preview: Sunshine Lake Pharma Co., Ltd. has filed an amendment to the Tender Offer/ Rights Offering Notificat...

    • Filing Date: March 11, 2025

      Accession Number: 000110465925022344

      Corporate Action: Merger

      Summary preview: The document is an amendment concerning the tender offer by Sunshine Lake Pharma Co., Ltd. for YiCha...

    • Filing Date: February 11, 2025

      Accession Number: 000110465925011068

      Corporate Action: Merger

      Summary preview: This document is an amendment notification regarding the tender offer of YiChang HEC ChangJiang Phar...

    • Filing Date: January 10, 2025

      Accession Number: 000110465925002349

      Corporate Action: Merger

      Summary preview: Sunshine Lake Pharma Co., Ltd. is filing an amendment to the tender offer regarding the proposed pre...

  • TNF Pharmaceuticals, Inc.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000164117225003814

      Corporate Action: Merger

      Summary preview: TNF Pharmaceuticals, Inc. filed its annual report for the fiscal year ended December 31, 2024. The r...

  • VALVOLINE INC

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000167491025000070

      Corporate Action: Merger

      Summary preview: Valvoline Inc. has entered into a Merger Agreement with OCI Merger Sub Inc. and OC IntermediateCo, i...

    • Filing Date: February 20, 2025

      Accession Number: 000167491025000043

      Corporate Action: Merger

      Summary preview: On February 17, 2025, Valvoline Inc. entered into a Merger Agreement to acquire OC IntermediateCo, w...

  • Village Bank & Trust Financial Corp.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000155837025004699

      Corporate Action: Merger

      Summary preview: Village Bank & Trust Financial Corp. has filed a Form 15 for the certification and notice of termina...

    • Filing Date: April 1, 2025

      Accession Number: 000155837025004237

      Corporate Action: Merger

      Summary preview: On April 1, 2025, Village Bank and Trust Financial Corp. completed a merger with TowneBank and its w...

    • Filing Date: December 19, 2024

      Accession Number: 000155837024016382

      Corporate Action: Merger

      Summary preview: The document reports the results of a special meeting of shareholders held by Village Bank & Trust F...

  • VOXX International Corp

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000110465925034032

      Corporate Action: Merger

      Summary preview: On April 1, 2025, VOXX International Corporation completed a merger where Instrument Merger Sub, Inc...

    • Filing Date: April 1, 2025

      Accession Number: 000110465925030420

      Corporate Action: Merger

      Summary preview: On April 1, 2025, VOXX International Corporation completed a merger with Gentex Corporation and its ...

    • Filing Date: April 1, 2025

      Accession Number: 000110465925030422

      Corporate Action: Merger

      Summary preview: On April 1, 2025, VOXX International Corporation filed a Post-Effective Amendment related to its Reg...

    • Filing Date: April 1, 2025

      Accession Number: 000110465925030424

      Corporate Action: Merger

      Summary preview: On April 1, 2025, VOXX International Corporation completed a merger with Gentex Corporation, where G...

    • Filing Date: April 1, 2025

      Accession Number: 000110465925030427

      Corporate Action: Merger

      Summary preview: On April 1, 2025, VOXX International Corporation filed a Post-Effective Amendment to deregister unso...

  • Wellgistics Health, Inc.

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000164117225003835

      Corporate Action: Merger

      Summary preview: On April 8, 2025, Wellgistics Health, Inc. entered into a Merger Agreement with Wellpeek Merger Sub ...

    • Filing Date: December 17, 2024

      Accession Number: 000149315224050512

      Corporate Action: Acquisition

      Summary preview: Wellgistics Health, Inc. submitted a Response to the SEC regarding comments received on Amendment No...

    • Filing Date: December 6, 2024

      Accession Number: 000149315224049101

      Corporate Action: Acquisition

      Summary preview: Wellgistics Health, Inc. submitted a response letter to the SEC regarding the comments received from...

    • Filing Date: October 18, 2024

      Accession Number: 000149315224041642

      Corporate Action: Acquisition

      Summary preview: Wellgistics Health, Inc. (previously known as Danam Health, Inc.) submitted a response letter to the...

  • XEROX CORP

    View details
    • Filing Date: April 11, 2025

      Accession Number: 000119312525079163

      Corporate Action: Acquisition

      Summary preview: On April 11, 2025, Xerox Corporation and its wholly-owned subsidiary, Xerox Issuer Corporation, comp...

    • Filing Date: February 24, 2025

      Accession Number: 000177045025000010

      Corporate Action: Acquisition

      Summary preview: Xerox Corporation announced significant strategic developments in their annual report for the fiscal...

    • Filing Date: February 5, 2025

      Accession Number: 000177045025000006

      Corporate Action: Acquisition

      Summary preview: Xerox Corporation completed its acquisition of ITsavvy Acquisition Company, Inc. on November 20, 202...

    • Filing Date: December 23, 2024

      Accession Number: 000119312524283670

      Corporate Action: Acquisition

      Summary preview: On December 22, 2024, Xerox Corporation entered into an Equity Purchase Agreement to acquire Lexmark...

  • Accolade, Inc.

    View details
    • Filing Date: April 10, 2025

      Accession Number: 000110465925033599

      Corporate Action: Merger

      Summary preview: This Amendment No. 1 relates to the Statement of Beneficial Ownership on Schedule 13D filed jointly ...

    • Filing Date: April 8, 2025

      Accession Number: 000114036125012765

      Corporate Action: Merger

      Summary preview: On April 8, 2025, Accolade, Inc. filed a Post-Effective Amendment No 1. to its Registration Statemen...

    • Filing Date: April 8, 2025

      Accession Number: 000114036125012719

      Corporate Action: Merger

      Summary preview: On April 8, 2025, Accolade, Inc. completed a merger with Transcarent, Inc. pursuant to the Agreement...

    • Filing Date: April 8, 2025

      Accession Number: 000114036125012766

      Corporate Action: Merger

      Summary preview: On April 8, 2025, Accolade, Inc. filed a Post-Effective Amendment No. 1 to its Form S-8 registration...

1 14 15 16 17 18 81